Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation
- 1 September 1989
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (3) , S39-S43
- https://doi.org/10.1016/0002-9343(89)80530-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.Journal of Clinical Investigation, 1987
- Case Report: Amelioration of Antithrombin III Deficiency by Coumarin AdministrationThe Lancet Healthy Longevity, 1987
- The Regulation of Natural Anticoagulant PathwaysScience, 1987
- Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.Journal of Clinical Investigation, 1985
- A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.Journal of Clinical Investigation, 1984
- Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.Journal of Clinical Investigation, 1984
- Natural anticoagulant mechanisms.Journal of Clinical Investigation, 1984
- Arachidonate metabolism in vascular disorders.Journal of Clinical Investigation, 1983
- The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.Journal of Clinical Investigation, 1976
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974